These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22482333)

  • 21. Compression behavior of orthorhombic paracetamol.
    Joiris E; Di Martino P; Berneron C; Guyot-Hermann AM; Guyot JC
    Pharm Res; 1998 Jul; 15(7):1122-30. PubMed ID: 9688070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation.
    Maniruzzaman M; Boateng JS; Bonnefille M; Aranyos A; Mitchell JC; Douroumis D
    Eur J Pharm Biopharm; 2012 Feb; 80(2):433-42. PubMed ID: 22108493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallization conditions and formation of orthorhombic paracetamol from ethanolic solution.
    Al-Zoubi N; Nikolakakis I; Malamataris S
    J Pharm Pharmacol; 2002 Mar; 54(3):325-33. PubMed ID: 11902798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.
    Qi S; Avalle P; Saklatvala R; Craig DQ
    Eur J Pharm Biopharm; 2008 May; 69(1):364-71. PubMed ID: 18036792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly compressible paracetamol: I: crystallization and characterization.
    Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Int J Pharm; 2000 Nov; 208(1-2):87-99. PubMed ID: 11064214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlling individual steps in the production process of paracetamol tablets by use of NIR spectroscopy.
    Blanco M; Cueva-Mestanza R; Peguero A
    J Pharm Biomed Anal; 2010 Mar; 51(4):797-804. PubMed ID: 19880266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children.
    Okereke B; Ibeleme O; Bisi-Onyemaechi A
    J Int Med Res; 2021 Mar; 49(3):300060521999755. PubMed ID: 33736533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality Evaluation of Locally Manufactured Paracetamol Tablets in East Africa.
    Marisa G; Kapala J; Mafuru T; Matinde R; Kimaro E; Kaale E
    Biomed Res Int; 2024; 2024():9437835. PubMed ID: 39310289
    [No Abstract]   [Full Text] [Related]  

  • 30. The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations.
    Kennedy JM; Tyers NM; Davey AK
    J Pharm Pharmacol; 2003 Oct; 55(10):1345-50. PubMed ID: 14607015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Determination of Acetaminophen and Synthetic Color(s) by Derivative Spectroscopy in Syrup Formulations and Validation by HPLC: Exposure Risk of Colors to Children.
    Rastogi SD; Dixit S; Tripathi A; Das M
    AAPS PharmSciTech; 2015 Jun; 16(3):505-17. PubMed ID: 25374343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction study of paracetamol with saturated (capric) and unsaturated (oleic) fatty acids.
    Misra AK; Misra M; Panpalia GM; Dorle AK
    Pharm Dev Technol; 2007; 12(4):423-8. PubMed ID: 17763147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions.
    Lloyd GR; Craig DQ; Smith A
    Eur J Pharm Biopharm; 1999 Jul; 48(1):59-65. PubMed ID: 10477330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treating pain after dental surgery: a randomised, controlled, double-blind trial to assess a new formulation of paracetamol, opium powder and caffeine versus tramadol or placebo].
    Borel JF; Deschaumes C; Devoize L; Huard C; Orliaguet T; Dubray C; Baudet-Pommel M; Dallel R
    Presse Med; 2010 May; 39(5):e103-11. PubMed ID: 20080382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ gelling pectin formulations for oral sustained delivery of paracetamol.
    Kubo W; Konno Y; Miyazaki S; Attwood D
    Drug Dev Ind Pharm; 2004 Jul; 30(6):593-9. PubMed ID: 15285332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubility prediction of paracetamol in water-ethanol-propylene glycol mixtures at 25 and 30 degrees C using practical approaches.
    Jouyban A; Azarmir O; Mirzaei S; Hassanzadeh D; Ghafourian T; Acree WE; Nokhodchi A
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):602-6. PubMed ID: 18379118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety profile of sustained release paracetamol during therapeutic use and following overdose.
    Dart RC; Green JL; Bogdan GM
    Drug Saf; 2005; 28(11):1045-56. PubMed ID: 16231956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paracetamol poisoning in infants aged less than six months: dosage errors].
    Fernández Landaluce A; Mintegi Raso S; Martínez González MJ
    An Pediatr (Barc); 2004 Feb; 60(2):177-9. PubMed ID: 14757024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ, real time observation of the disintegration of paracetamol tablets in aqueous solution by magnetic resonance imaging.
    Tritt-Goc J; Kowalczuk J
    Eur J Pharm Sci; 2002 May; 15(4):341-6. PubMed ID: 11988395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of formulation of mild pharmaceutical forms of paracetamol in medical practice.
    Abdullahu B; Morina N; Islami H
    Mater Sociomed; 2012; 24(3):148-50. PubMed ID: 23678321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.